Perrigo Company plc·Healthcare

The S&P 600 Small Cap index offers exposure to quality small-cap stocks with earnings requirements, providing growth potential and less analyst coverage. Eight S&P 600 small-cap dividend stocks meet the 'IDEAL' criteria: dividends from $1K invested exceed share price and free cash flow supports payouts. Top ten S&P 600 small-cap dividend dogs are projected to deliver an average 64.97% net gain by April 2027, with above-market volatility.

SG Americas Securities LLC boosted its holdings in shares of Perrigo Company plc (NYSE: PRGO) by 1,495.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 134,433 shares of the company's stock after buying an additional 126,008 shares during

DiaSorin (OTCMKTS:DSRLF - Get Free Report) and Perrigo (NYSE: PRGO - Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Analyst Ratings This is a summary of current ratings and

Perrigo offers a compelling value with a 12% dividend yield and a P/E of 4.3, trading at a deep discount to fair value. PRGO is refocused on its core OTC store-brand business, prioritizing cost savings and operational efficiencies after divestitures and past acquisition missteps. Management's Three-S Plan targets $80M–$100M in annual cost savings by 2027, supporting margin improvement and sustainable dividend growth.

O Keefe Stevens Advisory Inc. decreased its position in Perrigo Company plc (NYSE: PRGO) by 25.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 167,803 shares of the company's stock after selling 56,600 shares during the quarter. Perrigo

Investors love ultra-high-yield dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Healthcare
Drug Manufacturers - Specialty & Generic
8,379
1991-12-17
0.49